News | Ultrasound Women's Health | April 03, 2019

SuperSonic Imagine Highlights Aixplorer Mach 30 Breast Ultrasound at SBI/ACR Breast Imaging Symposium

New features on latest generation system include SWE Plus elastography, SonicPad touchpad

SuperSonic Imagine Highlights Aixplorer Mach 30 Breast Ultrasound at SBI/ACR Breast Imaging Symposium

April 3, 2019 — SuperSonic Imagine will introduce the new generation of its Aixplorer Mach 30 breast ultrasound solution at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla. The SBI‘s annual symposium is the largest breast imaging conference in the world and this year, the symposium will focus on Value in Breast Imaging. SuperSonic Imagine will highlight new features and better performance with features like SWE Plus and SonicPure.

The advantages of ShearWave Elastography (SWE) in the diagnosis of mammary lesions has been demonstrated in more than 135 articles in peer-reviewed journals, including an international study involving more than 1,600 patients1in the U.S. and Europe, and another study on population with dense breast realized in China in 1,021 women2. SWE improves the diagnostic performance of conventional ultrasonography by enhancing the characterisation and boosting the specificity of mammary lesions. It makes it possible to decrease the number negative biopsies.

The new Aixplorer Mach 30 is equipped with the next generation of ShearWave Plus (SWE Plus) elastography and offers an advanced breast imaging solution with enhanced speed of acquisition.

Both 2-D and 3-D patented SWE Plus offers greater performance of real-time, reliable, quantitative and reproducible evaluation of tissue stiffness and visualisation. SWE Plus provides new information and helps improve the identification of malignant or benign lesions. It offers greater diagnostic precision, which considerably reduces the number of false positives and unnecessary biopsies.

SuperSonic Imagine also offers numerous innovative imaging modes to improve the efficacy of breast examinations and patient comfort. Needle PL.U.S offers increased reliability during procedures guided by ultrasound and biopsies. The application enables physicians to view anatomical structures and biopsy needles simultaneously and predict their trajectory in real time. Angio PL.U.S offers high resolution for imaging microvascularization of lesions. TriVu combines real-time simultaneous imaging of B-mode, ShearWave Plus and Angio PL.U.S. enabling users to visualize the anatomy, function (tissue stiffness) and blood flow on the same image simultaneously.  

Aixplorer Mach 30 features a new concept in ultrasound, according to the company, with its SonicPad touchpad, designed to enhance the user experience. With its intuitive touch screen interface, SonicPad offers intuitive control of all the functions needed to conduct the exam. It allows imagers to focus their attention on analyzing the clinical information displayed on the screen rather than on the controls used to optimise the acquisition of an image.

For more information: www.aixplorer-mach.com

 

References

1. Berg W.A., Zhang Z., Lehrer D., et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012 Apr 4;307(13):1394-404.

2. Lee S.H., Chung J., Choi H.Y., et al. Evaluation of Screening US-detected Breast Masses by Combined Use of Elastography and Color Doppler US with B-Mode US in Women with Dense Breasts: A Multicenter Prospective Study. Radiology. 2017 Nov;285(2):660-669.

Related Content

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Videos | Point-of-Care Ultrasound (POCUS) | April 01, 2021
Here are two quick clinical examples of point-of-care ultrasound (POCUS) lung imaging and cardiac imaging using a GE
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to d
In looking at the broader impact of the COVID-19 pandemic on health and wellbeing, public health experts are examining screening rates for cancer. A new study looking at U.S. mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — In looking at the broader impact of the...
ScImage, Inc. celebrates its cloud partnership with Digirad Health (“Digirad”), a division of Star Equity Holdings, after a year of successful deployment of PICOM365 for mobile imaging. Digirad’s fleet of mobile SPECT, echocardiology, vascular and general ultrasound units combined with PICOM365’s cloud image management workflow leverage each company’s strengths to create an exemplary reading and reporting environment.
News | Archive Cloud Storage | March 30, 2021
March 30, 2021 — ScImage, Inc.